Clinical treatments to promote cell survival for ischemic stroke have been limited to thrombolytic therapy using tissue plasminogen activator (tPA) or thrombectomy by mechanical means, which can benefit only a limited number of patients [2-5]. Here, PLAT is linked to ischemic stroke.